Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.
- DOI
- 10.1002/epi.70371
- Published
- 2026 Jul 4
- Container
- Epilepsia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/epi.70371,
title = {Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.},
author = {Gil-Nagel A and Knupp KG and Gunning B and Battaglia DI and Thiele EA and Scheffer IE and Schoonjans AS and Nabbout R and Villeneuve N and Klotz KA and Specchio N and Sanchez-Carpintero R and Zolnowska M and Schulz AL and Perrin L and Dickson N and Langlois M and Lothe A and Sullivan J},
year = {2026},
journal = {Epilepsia},
doi = {10.1002/epi.70371},
url = {https://doi.org/10.1002/epi.70371}
}RIS
TY - JOUR TI - Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness. AU - Gil-Nagel A AU - Knupp KG AU - Gunning B AU - Battaglia DI AU - Thiele EA AU - Scheffer IE AU - Schoonjans AS AU - Nabbout R AU - Villeneuve N AU - Klotz KA AU - Specchio N AU - Sanchez-Carpintero R AU - Zolnowska M AU - Schulz AL AU - Perrin L AU - Dickson N AU - Langlois M AU - Lothe A AU - Sullivan J PY - 2026 JO - Epilepsia DO - 10.1002/epi.70371 UR - https://doi.org/10.1002/epi.70371 ER -
APA
A, G., KG, K., B, G., DI, B., EA, T., IE, S., AS, S., R, N., N, V., KA, K., N, S., R, S., M, Z., AL, S., L, P., N, D., M, L., A, L., & J, S. (2026). Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.. Epilepsia. https://doi.org/10.1002/epi.70371
Source records
- pubmed · retrieved 2026-09-26T11:14:25.958Z